Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Oct 4:15:1480739.
doi: 10.3389/fimmu.2024.1480739. eCollection 2024.

Impaired Mycobacterium tuberculosis-specific T-cell memory phenotypes and functional profiles among adults with type 2 diabetes mellitus in Uganda

Affiliations

Impaired Mycobacterium tuberculosis-specific T-cell memory phenotypes and functional profiles among adults with type 2 diabetes mellitus in Uganda

Phillip Ssekamatte et al. Front Immunol. .

Abstract

Background: Efforts to eradicate tuberculosis (TB) are threatened by diabetes mellitus (DM), which confers a 3-fold increase in the risk of TB disease. The changes in the memory phenotypes and functional profiles of Mycobacterium tuberculosis (Mtb)-specific T cells in latent TB infection (LTBI)-DM participants remain poorly characterised. We, therefore, assessed the effect of DM on T-cell phenotype and function in LTBI and DM clinical groups.

Methods: We compared the memory phenotypes and function profiles of Mtb-specific CD4+ and CD8+ T cells among participants with LTBI-DM (n=21), LTBI-only (n=17) and DM-only (n=16). Peripheral blood mononuclear cells (PBMCs) were stimulated with early secretory antigenic 6 kDa (ESAT-6) and culture filtrate protein 10 (CFP-10) peptide pools or phytohemagglutinin (PHA). The memory phenotypes (CCR7/CD45RA), and functional profiles (HLA-DR, PD-1, CD107a, IFN-γ, IL-2, TNF, IL-13, IL-17A) of Mtb-specific CD4+ and CD8+ T cells were characterised by flow cytometry.

Results: Naïve CD4+ T cells were significantly decreased in the LTBI-DM compared to the LTBI-only participants [0.47 (0.34-0.69) vs 0.91 (0.59-1.05); (p<0.001)]. Similarly, CD8+ HLA-DR expression was significantly decreased in LTBI-DM compared to LTBI-only participants [0.26 (0.19-0.33) vs 0.52 (0.40-0.64); (p<0.0001)], whereas CD4+ and CD8+ PD-1 expression was significantly upregulated in the LTBI-DM compared to the LTBI-only participants [0.61 (0.53-0.77) vs 0.19 (0.10-0.28); (p<0.0001) and 0.41 (0.37-0.56) vs 0.29 (0.17-0.42); (p=0.007)] respectively. CD4+ and CD8+ IFN-γ production was significantly decreased in the LTBI-DM compared to the LTBI-only participants [0.28 (0.19-0.38) vs 0.39 (0.25-0.53); (p=0.030) and 0.36 (0.27-0.49) vs 0.55 (0.41-0.88); (p=0.016)] respectively. CD4+ TNF and CD8+ IL-17A production were significantly decreased in participants with LTBI-DM compared to those with LTBI-only [0.38 (0.33-0.50) vs 0.62 (0.46-0.87); (p=0.004) and 0.29 (0.16-0.42) vs 0.47 (0.29-0.52); (0.017)] respectively. LTBI-DM participants had significantly lower dual-functional (IFN-γ+IL-2+ and IL-2+TNF+) and mono-functional (IFN-γ+ and TNF+) CD4+ responses than LTBI-only participants. LTBI-DM participants had significantly decreased dual-functional (IFN-γ+IL-2+, IFN-γ+ TNF+ and IL-2+TNF+) and mono-functional (IFN-γ+, IL-2+ and TNF+) central and effector memory CD4+ responses compared to LTBI-only participants.

Conclusion: Type 2 DM impairs the memory phenotypes and functional profiles of Mtb-specific CD4+ and CD8+ T cells, potentially indicating underlying immunopathology towards increased active TB disease risk.

Keywords: T cells; diabetes mellitus; functional profiles; latent tuberculosis infection; memory phenotypes.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted without any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Type 2 DM alters the memory phenotype of Mtb-specific CD4+ and CD8+ T cells. (A, B) Representative flow cytometry plots are shown for CD4+ and CD8+ CCR7/CD45RA-defined T-cell memory subsets, respectively. PBMCs were stimulated and cultured for 18 hours with ESAT-6 and CFP-10 peptide pools plus brefeldin A and stained for surface markers. (C, D) Percentage expression of memory phenotypes in CD4+ and CD8+T cells, respectively. (E, F) Heat maps for the percentage distribution of all memory phenotypes in the three CD4+ and CD8+ T cell participant groups. Size of participant groups: LTBI-DM (n = 21), LTBI (n = 17), DM (n = 16). Data represent medians and interquartile ranges. The non-parametric Kruskal-Wallis and Mann-Whitney U tests were used to determine the statistical significance between the medians. p<0.05 (*), p< 0.01 (**), p<0.001 (***). Non-significant p-values were not shown.
Figure 2
Figure 2
Type 2 DM impairs the HLA-DR, PD-1, and CD107A expression of Mtb-specific CD4+ and CD8+ T cells. The PBCMs were surface stained with HLA-DR and PD-1 antibodies after 18 hours of incubation with ESAT-6 and CFP-10 peptide pools and brefeldin A. (E, F) For degranulation analysis of CD4+ and CD8+ T cells, CD107a was added during stimulation. (A-D) Representative plots for HLA-DR and PD-1. Size of participant groups: LTBI-DM (n = 21), LTBI (n = 17), DM (n = 16). Data represent medians and interquartile ranges. The non-parametric Kruskal-Wallis and Mann-Whitney U tests were used to determine the statistical significance between the medians. p< 0.05 (*), p< 0.01 (**), p<0.001 (***) and p< 0.0001 (****). Non-significant p-values were not shown.
Figure 3
Figure 3
Type 2 DM impairs the production of Mtb-specific Th-1, Th-2 and Th-17 cytokines by CD4+ and CD8+ T cells. The PBMCs were cultured and stimulated for 18 hours with ESAT-6 and CFP-10 peptide pools, brefeldin A, and intracellularly stained for cytokines. (A-J) Representative plots for CD4+ and CD8+ T-cell producing TNF, IFN-γ, IL-2, IL-13, IL-17A cytokines. Size of participant groups: LTBI-DM (n = 21), LTBI (n = 17), DM (n = 16). Data represent medians and interquartile ranges. The non-parametric Kruskal-Wallis and Mann-Whitney U tests were used to determine the statistical significance between the medians. p< 0.05 (*), p< 0.01 (**). Non-significant p-values were not shown.
Figure 4
Figure 4
Type 2 DM impairs dual and mono-functional Mtb-specific CD4+ and CD8+ T-cell responses. (A) Polyfunctional Mtb-specific CD4+ T-cell responses. (B) Polyfunctional Mtb-specific CD8+ T-cell responses. The X-axis represents the frequencies of Mtb-specific CD4+ T cells producing all possible IFN-γ, IL-2 and TNF combinations. Data represent medians and interquartile ranges. The non-parametric Kruskal-Wallis and Mann-Whitney U tests were used to determine the statistical significance between the medians. p< 0.05 (*), p< 0.01 (**), p<0.001 (***) and p< 0.0001 (****).
Figure 5
Figure 5
Type 2 DM impairs triple, dual, mono-functional Mtb-specific central and effector memory CD4+ T-cell responses. (A) Polyfunctional Mtb-specific central memory CD4+ T-cell responses. (B) Polyfunctional Mtb-specific effector memory CD4+ T-cell responses. The X-axis represents the frequencies of Mtb-specific central and effector memory CD4+ T cells producing all possible combinations of IFN-γ, IL-2 and TNF. Data represent medians and interquartile ranges. Kruskal-Wallis and Mann-Whitney U tests were used to determine the statistical significance between the medians. p< 0.05 (*), p< 0.01 (**), p<0.001 (***) and p< 0.0001 (****). CM, Central memory; EM, Effector memory.

References

    1. Siddiqui AN, Hussain S, Siddiqui N, Khayyam KU, Tabrez S, Sharma M. Detrimental association between diabetes and tuberculosis: An unresolved double trouble. Diabetes Metab Syndrome: Clin Res Rev. (2018) 12:1101–7. doi: 10.1016/j.dsx.2018.05.009 - DOI - PubMed
    1. Sun H, Saeedi P, Karuranga S. IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res Clin Prac. (2022) 183:109119. doi: 10.1016/j.diabres.2021.109119 - DOI - PMC - PubMed
    1. World Health Organization . Global tuberculosis report 2023. Geneva: WHO; (2023).
    1. Jeon CY, Murray MB. Diabetes mellitus increases the risk of active tuberculosis: a systematic review of 13 observational studies. PLoS Med. (2008) 5:e152. doi: 10.1371/journal.pmed.0050152 - DOI - PMC - PubMed
    1. Kibirige D, Andia-Biraro I, Olum R, Adakun S, Zawedde-Muyanja S, Sekaggya-Wiltshire C, et al. . Tuberculosis and diabetes mellitus comorbidity in an adult Ugandan population. BMC Infect Diseases. (2024) 24:242. doi: 10.1186/s12879-024-09111-8 - DOI - PMC - PubMed